Cargando…

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells

BACKGROUND: Triple-Negative Breast Cancer (TNBC) is a subtype of breast cancer that differs from other types of breast cancers in the faster spread and worse outcome. TNBC presented limited treatment options. BET (Bromodomain and extra-terminal domain) proteins are epigenetic readers that control th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Teresa, Zamponi, Raffaella, Chirico, Mattea, Pisanu, Maria Elena, Iorio, Egidio, Torricelli, Federica, Gugnoni, Mila, Ciarrocchi, Alessia, Pistoni, Mariaelena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817244/ https://www.ncbi.nlm.nih.gov/pubmed/36604676 http://dx.doi.org/10.1186/s13046-022-02571-3

Ejemplares similares

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
por: Gugnoni, Mila, et al.
Publicado: (2022)

HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
por: Manzotti, Gloria, et al.
Publicado: (2019)

A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
por: Vitale, Emanuele, et al.
Publicado: (2022)

Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)()
por: Schreiber, Renate, et al.
Publicado: (2019)

Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer
por: Gugnoni, Mila, et al.
Publicado: (2019)

No Need to Stick Together to Be Connected: Multiple Types of Enhancers’ Networking
por: Vitale, Emanuele, et al.
Publicado: (2021)

Interaction between the Triglyceride Lipase ATGL and the Arf1 Activator GBF1
por: Ellong, Emy Njoh, et al.
Publicado: (2011)

Metabolomic Reprogramming Detected by (1)H-NMR Spectroscopy in Human Thyroid Cancer Tissues
por: Metere, Alessio, et al.
Publicado: (2020)

A combination strategy targeting enhancer plasticity exerts synergistic lethality against BETi-resistant leukemia cells
por: Guo, Lei, et al.
Publicado: (2020)

The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly
por: Vieyres, Gabrielle, et al.
Publicado: (2020)

KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)
por: Lorenzini, Eugenia, et al.
Publicado: (2022)

BETi induction of mitotic catastrophe: towing the LIN9
por: Gayle, Sylvia S., et al.
Publicado: (2017)

Structure–activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL)
por: Mayer, Nicole, et al.
Publicado: (2015)

Blocking Lipid Uptake Pathways Does not Prevent Toxicity in Adipose Triglyceride Lipase (ATGL) Deficiency
por: Oluwadare, Jide, et al.
Publicado: (2022)

Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
por: Gugnoni, Mila, et al.
Publicado: (2016)

Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific
por: Jocken, Johan W. E., et al.
Publicado: (2008)

LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL)
por: Chen, Gang, et al.
Publicado: (2016)

Adipose triglyceride lipase (Atgl) mediates the antibiotic jinggangmycin-stimulated reproduction in the brown planthopper, Nilaparvata lugens Stål
por: Jiang, Yi-Ping, et al.
Publicado: (2016)

Application of a sensitive collection heuristic for very large protein families: Evolutionary relationship between adipose triglyceride lipase (ATGL) and classic mammalian lipases
por: Schneider, Georg, et al.
Publicado: (2006)

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)
por: Bian, Benjamin, et al.
Publicado: (2019)

Recent Advances on the Role of ATGL in Cancer
por: Zhang, Renshuai, et al.
Publicado: (2022)

Measurement of ATGL activity using adiposomes
por: Ma, Xuejing, et al.
Publicado: (2023)

Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer
por: Mustafi, Sushmita, et al.
Publicado: (2019)

Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2023)

AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism
por: Vitaliti, Alessandra, et al.
Publicado: (2022)

MALAT1 as a Regulator of the Androgen-Dependent Choline Kinase A Gene in the Metabolic Rewiring of Prostate Cancer
por: De Martino, Sara, et al.
Publicado: (2022)

Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7
por: Gugnoni, Mila, et al.
Publicado: (2023)

Ilustraciones para el cuento Mi tía Beti de María Esther Hernández Palacios Mirón
por: Torres López, Thalia Ivonne
Publicado: (2012)

Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia
por: Kansal, Anuraag R., et al.
Publicado: (2021)

The Minimal Domain of Adipose Triglyceride Lipase (ATGL) Ranges until Leucine 254 and Can Be Activated and Inhibited by CGI-58 and G0S2, Respectively
por: Cornaciu, Irina, et al.
Publicado: (2011)

Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells
por: Zagani, Rachid, et al.
Publicado: (2015)

Hints on ATGL implications in cancer: beyond bioenergetic clues
por: Vegliante, Rolando, et al.
Publicado: (2018)

GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma
por: Gallo Cantafio, Maria Eugenia, et al.
Publicado: (2023)

Lipid rafts mediate multilineage differentiation of human dental pulp-derived stem cells (DPSCs)
por: Santilli, Francesca, et al.
Publicado: (2023)

RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
por: Sancisi, Valentina, et al.
Publicado: (2017)

Novel BET protein Proteolysis Targeting Chimera (BET-PROTAC) exerts superior lethal activity than Bromodomain Inhibitor (BETi) against post-myeloproliferative Neoplasm (MPN) Secondary (s) AML Cells
por: Saenz, Dyana T., et al.
Publicado: (2017)

GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC
por: Mabrouk, Nesrine, et al.
Publicado: (2023)

Distinct roles for α-β hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling
por: Lord, Caleb C., et al.
Publicado: (2012)

Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells
por: Saulle, Ernestina, et al.
Publicado: (2021)

Effect of Global ATGL Knockout on Murine Fasting Glucose Kinetics
por: Coelho, Margarida, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fh0k2obkffs44riu6v9fah7199